Skip to main content
Back to Global Brain Corporation

Global Brain Corporation's Therapeutics Portfolio

Browse 9 Therapeutics companies funded by Global Brain Corporation. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
9
Total Funding in Therapeutics
$161.6M

Therapeutics Portfolio Companies (9)

Export
BiotechnologyLife ScienceTherapeutics

ThinkCyte is a biotechnology company that provides sorting of cells for various applications in research, diagnostics, and therapeutics.

Hongo, Japan
August 2024
$14.8M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).

Bristol, United Kingdom
July 2023
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyProduct ResearchTherapeutics

Metaphore Biotechnologies is a firm that uses biomimicry and machine learning to unlock the revolutionary therapeutic.

Cambridge, United States
April 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareNeuroscienceTherapeutics

Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.

Boston, United States
March 2026
$3.3M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Boston, United States
September 2024
$65.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyTherapeutics

Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

San Carlos, United States
March 2024
$12.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalTherapeutics

Switch Therapeutics is a biotech company that develops RNAi therapies.

San Francisco, United States
March 2023
$52.0M
Series A

Founder Contacts

30,000+ verified contacts

MedicalPharmaceuticalTherapeutics

Alpha Fusion is a clinical research company that focuses on cancer treatment through the design and development of radiopharmaceuticals.

Osaka, Japan
October 2024
$6.9M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedicalTherapeutics

Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.

Tsuruoka, Japan
February 2026
$7.6M
Series B

Founder Contacts

30,000+ verified contacts

Explore Global Brain Corporation's Full Portfolio

View all companies funded by Global Brain Corporation across every industry and funding stage.

View Full Global Brain Corporation Portfolio